“It’s not often that a single product catapults a whole industry upward,” writes business newspaper Handelsblatt, but then again the product offered by German coronavirus vaccine developer BioNTech is no ordinary one.
In the global race to deal with Covid-19, Germany’s extensive network of pharmaceutical companies are involved in major international collaborations and are benefiting from generous government support. German pharma is driving digitalization forward.
Global exports may be down because of the various restrictions associated with the Covid-19 pandemic, but 2020 is shaping up to be an excellent year for German pharmaceutical companies.
With the entire world looking for responses to the coronavirus pandemic, Germany’s pharmaceutical companies are attracting considerable attention. We asked Han Steutel, the president of the German Association of Research-Based Pharmaceutical Companies, for an update on the progress in developing anti-corona medications.
Over the Counter (OTC): People in Germany have been self-medicating more and more in recent years. Sales of prescription-free drugs are increasing at pharmacies and through online mail order services. Why?
Germany’s digital quantum leap is a priority for the new coalition government – and international companies are invited to help jump-start the future.
In 2021, the Investment and Marketing Corporation Saxony-Anhalt (IMG) acquired 68 new projects and helped 20 companies make the decision to move to the region, creating 2,019 new permanent jobs.
Germany’s single-cell biotechnology sector is transforming cancer treatments by shining a light on the genetic activity of individual cells. It’s also advancing our understanding of how our immune defences respond to Covid-19.
Germany’s governing cabinet has drawn up contracts with five companies to deliver anti-coronavirus vaccines until 2029. The companies in question are BioNTech, Curevac/GSK, Wacker/CordenPharma, Celonic and IDT.
Belén Garijo made history in May 2021 when she became CEO of pharmaceutical giant Merck as the first non-German to head the 350-year-old company, and also the first woman to lead a DAX company on her own.
Suchergebnis nicht zufriedenstellend? Versuche es mal mit einem Wort oder einer anderen Schreibweise
